{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:11:33Z","timestamp":1772928693735,"version":"3.50.1"},"reference-count":11,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2026,2,28]]},"DOI":"10.5582\/ddt.2025.01104","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:08:27Z","timestamp":1771538907000},"page":"71-79","source":"Crossref","is-referenced-by-count":0,"title":["Three-dimensional imaging provides reliable size measurement of skin lesions associated with vascular anomalies: A comparison with two-dimensional photography"],"prefix":"10.5582","volume":"20","author":[{"given":"Kana","family":"Sakai","sequence":"first","affiliation":[{"name":"Department of Dermatology, Wakayama Medical University, Wakayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Kunimoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wakayama Medical University, Wakayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuna","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wakayama Medical University, Wakayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wakayama Medical University, Wakayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wakayama Medical University, Wakayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Yasue","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Nozawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Ozeki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Jinnin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wakayama Medical University, Wakayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","unstructured":"1. International Society for the Study of Vascular Anomalies. ISSVA classification of vascular anomalies[Internet]. 2025[cited 2025 May 28]. Available from: <i>https:\/\/www.issva.org\/classification<\/i> (accessed May 28, 2025)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kunimoto K, Yamamoto Y, Jinnin M. ISSVA Classification of Vascular Anomalies and Molecular Biology. Int J Mol Sci. 2022; 23:2358.","DOI":"10.3390\/ijms23042358"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ozeki M, Nozawa A, Yasue S, Endo S, Asada R, Hashimoto H, Fukao T. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies. Orphanet J Rare Dis. 2019; 14:141.","DOI":"10.1186\/s13023-019-1118-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ozeki M, Endo S, Yasue S <i>et al<\/i>. Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial. Front Med (Lausanne). 2024; 11:1335469.","DOI":"10.3389\/fmed.2024.1335469"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Singh S, Bradford D, Li X <i>et al<\/i>. FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum. Clin Cancer Res. 2024; 30:23-28.","DOI":"10.1158\/1078-0432.CCR-23-1270"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chaby G, Lok C, Thirion JP, Lucien A, Senet P. Three-dimensional digital imaging is as accurate and reliable to measure leg ulcer area as transparent tracing with digital planimetry. J Vasc Surg Venous Lymphat Disord. 2017; 5:837-843.","DOI":"10.1016\/j.jvsv.2017.05.019"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bharadia SK, Gabriel V. Comparison of Clinical Estimation and Stereophotogrammic Instrumented Imaging of Burn Scar Height and Volume. Eur Burn J. 2024; 5:38-48.","DOI":"10.3390\/ebj5010004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bonan P, Verdelli A. Combined microwaves and fractional microablative CO2 laser treatment for postpartum abdominal laxity. J Cosmet Dermatol. 2021; 20:124-131.","DOI":"10.1111\/jocd.13510"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979; 86:420-428.","DOI":"10.1037\/\/0033-2909.86.2.420"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas. 1973; 33:613-619.","DOI":"10.1177\/001316447303300309"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jinnin M, Shimokawa T, Kishi A <i>et al<\/i>. Topical sirolimus therapy for cutaneous vascular anomalies: A Randomized Phase II Clinical Trial. J Dermatol. 2025; 52:872-887.","DOI":"10.1111\/1346-8138.17688"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/20\/1\/20_2025.01104\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:38:56Z","timestamp":1772858336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/20\/1\/20_2025.01104\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2025.01104","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"article-number":"2025.01104"}}